These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17555462)

  • 1. National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing.
    Mahmud A; Bennett K; Okechukwu I; Feely J
    Br J Clin Pharmacol; 2007 Nov; 64(5):706-9. PubMed ID: 17555462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation.
    Lleva P; Aronow WS; Gutwein AH
    Am J Ther; 2009; 16(6):e41-3. PubMed ID: 19940604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation].
    Han W; Shen DT; Wang YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):851-2, 855. PubMed ID: 16793618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for patients with atrial fibrillation in ambulatory care settings.
    Niska R; Han B
    J Am Board Fam Med; 2009; 22(3):299-306. PubMed ID: 19429736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is warfarin underused in the treatment of elderly persons with atrial fibrillation?
    Whittle J; Wickenheiser L; Venditti LN
    Arch Intern Med; 1997 Feb; 157(4):441-5. PubMed ID: 9046896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation.
    Burkiewicz JS
    Pharmacotherapy; 2005 Aug; 25(8):1062-7. PubMed ID: 16207096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing patterns for the use of antithrombotics in the management of atrial fibrillation in Zimbabwe.
    Bhagat K; Tisocki K
    Cent Afr J Med; 1999 Nov; 45(11):287-90. PubMed ID: 10892453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilemmas in geriatrics: scenario 1 results.
    Kopp D; Gray CS
    WMJ; 2001; 100(9):9-10. PubMed ID: 11868523
    [No Abstract]   [Full Text] [Related]  

  • 11. I have atrial fibrillation and take warfarin, digoxin and metoprolol. I still get an occasional mild attack, however. Is this normal?
    Duke Med Health News; 2009 Nov; 15(11):8. PubMed ID: 20027694
    [No Abstract]   [Full Text] [Related]  

  • 12. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
    Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing between warfarin (Coumadin) and aspirin therapy for patients with atrial fibrillation.
    Ebell MH
    Am Fam Physician; 2005 Jun; 71(12):2348-50. PubMed ID: 15999873
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database).
    O'Hara GE; Charbonneau L; Chandler M; Vidaillet HJ; Philippon F; Sami M; Rocco TA; Padder FA; Champagne J; Pratt CM; Coutu B; Wyse DG;
    Am J Cardiol; 2005 Sep; 96(6):815-21. PubMed ID: 16169368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making.
    Man-Son-Hing M; Gage BF; Montgomery AA; Howitt A; Thomson R; Devereaux PJ; Protheroe J; Fahey T; Armstrong D; Laupacis A
    Med Decis Making; 2005; 25(5):548-59. PubMed ID: 16160210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
    Allen Lapointe NM; Sun JL; Kaplan S; d'Almada P; Al-Khatib SM
    Am J Cardiol; 2008 Apr; 101(8):1134-41. PubMed ID: 18394447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "pill-in-the-pocket" approach to atrial fibrillation.
    Wittkowsky AK
    N Engl J Med; 2005 Mar; 352(11):1150-1; author reply 1150-1. PubMed ID: 15789456
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
    Rash A; Downes T; Portner R; Yeo WW; Morgan N; Channer KS
    Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should we manage newly diagnosed atrial fibrillation?
    Holten KB
    J Fam Pract; 2004 Aug; 53(8):641-3. PubMed ID: 15298837
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.